BRAF: A New Target to Treat in Lung Cancer
16 lug 2015 ·
4 min. 18 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
A study released at ASCO 2015 showed that the BRAF V600E mutation had a high response rate to combination therapy Tafinlar (dabrafenib) plus Mekinist (trametinib), which led the doctors to...
mostra di più
A study released at ASCO 2015 showed that the BRAF V600E mutation had a high response rate to combination therapy Tafinlar (dabrafenib) plus Mekinist (trametinib), which led the doctors to agree that BRAF testing in lung cancer should become commonplace.
mostra meno
Informazioni
Autore | cancerGRACE |
Organizzazione | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company